AstraZeneca
AZN
AZN
1,222 hedge funds and large institutions have $39B invested in AstraZeneca in 2024 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 496 increasing their positions, 397 reducing their positions, and 88 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $39B → $39B (+$49.9M)
0.07% more ownership
Funds ownership: 32.2% → 32.26% (+0.07%)
11% less funds holding in top 10
Funds holding in top 10: 18 → 16 (-2)
Holders
1,222
Holding in Top 10
16
Calls
$485M
Puts
$334M
Top Buyers
| 1 | +$780M | |
| 2 | +$193M | |
| 3 | +$125M | |
| 4 |
D.E. Shaw & Co
New York
|
+$121M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$119M |
Top Sellers
| 1 | -$259M | |
| 2 | -$197M | |
| 3 | -$188M | |
| 4 |
Jennison Associates
New York
|
-$160M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$159M |